Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.42 |
| ▸ | MAOA | P21397 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | CALML3 | P27482 | 1/20 | 0.41 |
| ▸ | SDHA | P31040 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 11/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4174854 | 1.00 | MAOB (0.42) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4174135 | 0.91 | MAOB (0.40) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4174141 | 0.91 | MAOB (0.40) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4177073 | 0.90 | MAOA (0.52) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4181753 | 0.90 | MAOA (0.52) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4162995 | 0.89 | MAOB (0.54) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4162993 | 0.89 | MAOB (0.54) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4158414 | 0.88 | MAOA (0.42) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4160628 | 0.88 | MAOA (0.42) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL4163662 | 0.88 | MAOA (0.43) | MAOBMAOALMNAPTGS1CALML3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090018123-A1 | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation | SINDKHEDKAR MILIND D | 2009-01-15 | — | — | US | disclosed |
| EP-1912980-A2 | OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION | Wockhardt Limited (IN) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007023507-A2 | OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION | WOCKHARDT LIMITED (IN) | 2007-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018123-A1 | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation | POLL, POLM, POLRMT | MAOB 3240/4885MAOA 3788/4885LMNA 1529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.